| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |